Journal of the American Pharmacists Association : JAPhA · 2013
Adherence and persistence associated with an appointment-based medication synchronization program.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Holdford David A, Inocencio Timothy J
Аннотация
OBJECTIVE: To assess the impact of an appointment-based medication synchronization (ABMS) program on medication adherence and persistence with chronic medications. DESIGN Quasiexperimental study in which study patients were matched with control patients.
SETTING: Rural pharmacies in the Midwestern United States between June 30, 2011, and October 31, 2012.
PATIENTS: Individuals receiving at least two refills for one of six categories of medications to treat chronic diseases (i.e., angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, dihydropyridine calcium channel blockers, thiazide diuretics, metformin, statins).
INTERVENTION: Patients in the ABMS program were compared with control patients receiving usual care.
MAIN OUTCOME MEASURES: 1-year adherence rates using proportion of days covered (PDC) and 1-year nonpersistence rates.
RESULTS: Depending on the drug class, patients enrolled in the medication synchronization program (n = 47-81) had adherences rates of 66.1% to 75.5% during 1 year versus 37.0% to 40.8% among control patients. Program patients had 3.4 to 6.1 times greater odds of adherence compared with control patients. Control patients were 52% to 73% more likely to stop taking their chronic medications over 1 year.
CONCLUSION: An ABMS program in community pharmacies was associated with improved patient adherence and reduced likelihood of nonpersistence.
SETTING: Rural pharmacies in the Midwestern United States between June 30, 2011, and October 31, 2012.
PATIENTS: Individuals receiving at least two refills for one of six categories of medications to treat chronic diseases (i.e., angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, dihydropyridine calcium channel blockers, thiazide diuretics, metformin, statins).
INTERVENTION: Patients in the ABMS program were compared with control patients receiving usual care.
MAIN OUTCOME MEASURES: 1-year adherence rates using proportion of days covered (PDC) and 1-year nonpersistence rates.
RESULTS: Depending on the drug class, patients enrolled in the medication synchronization program (n = 47-81) had adherences rates of 66.1% to 75.5% during 1 year versus 37.0% to 40.8% among control patients. Program patients had 3.4 to 6.1 times greater odds of adherence compared with control patients. Control patients were 52% to 73% more likely to stop taking their chronic medications over 1 year.
CONCLUSION: An ABMS program in community pharmacies was associated with improved patient adherence and reduced likelihood of nonpersistence.